Andrew C Harris
Overview
Explore the profile of Andrew C Harris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2680
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meyers G, Hamadani M, Martens M, Ali H, Chevallier P, Choe H, et al.
Bone Marrow Transplant
. 2025 Feb;
PMID: 40016514
No abstract available.
2.
Bhatt N, Harris A, Gorfinkel L, Ibanez K, Tkaczyk E, Mitchell S, et al.
Transplant Cell Ther
. 2024 Dec;
31(2):69.e1-69.e18.
PMID: 39701289
Current literature lacks details on the impact of pediatric chronic graft-versus-host disease (cGVHD) on long-term survivorship after allogeneic hematopoietic cell transplantation (HCT). Nonetheless, cGVHD remains a leading cause of post-transplant...
3.
Harris A, Ganjaei K, Vilela C, Geyer A
Transplant Cell Ther
. 2024 Oct;
30(9S):S585-S596.
PMID: 39370238
No abstract available.
4.
Liu S, Harris A, Gewirtz J
Front Mol Neurosci
. 2024 Oct;
17:1462769.
PMID: 39359689
Substance use disorder (SUD) represents a large and growing global health problem. Despite the strong addictive potency of drugs of abuse, only a minority of those exposed develop SUDs. While...
5.
Harris A, Markova A, Devlin S, Singh A, Susman P, Brown S, et al.
Transplant Cell Ther
. 2024 Sep;
30(12):1215.e1-1215.e11.
PMID: 39303987
Graft-versus-host disease (GVHD) is a complication following allogeneic hematopoietic cell transplant that frequently causes multiorgan affection and decrease in quality of life. Global assessment and care of these patients require...
6.
Harris A, Muelken P, Liu S, Smethells J, Lesage M, Gewirtz J
Front Behav Neurosci
. 2024 Sep;
18:1443364.
PMID: 39267985
Introduction: Sex differences in vulnerability to opioid use disorder (OUD) have been reported in some clinical and preclinical studies, but findings are mixed and further research is needed in this...
7.
Liu S, Muelken P, Maxim Z, Ramakrishnan A, Estill M, Lesage M, et al.
bioRxiv
. 2024 Jul;
PMID: 38979145
Opioid use disorder (OUD) is a neuropsychological disease that has a devastating impact on public health. Substantial individual differences in vulnerability exist, the neurobiological substrates of which remain unclear. To...
8.
Takahashi T, Watkins B, Bratrude B, Neuberg D, Hebert K, Betz K, et al.
Transplant Cell Ther
. 2024 Apr;
31(2):109.e1-109.e13.
PMID: 38583802
Although unrelated-donor (URD) hematopoietic cell transplantation (HCT) is associated with many toxicities, a detailed analysis of adverse events, as defined by the Common Terminology Criteria for Adverse Events (CTCAE), has...
9.
Major-Monfried H, Hosszu K, McAvoy D, Vallone A, Shukla N, Gillio A, et al.
Cytotherapy
. 2024 Mar;
26(5):466-471.
PMID: 38430078
Background Aims: Daratumumab, a human IgG monoclonal antibody targeting CD38, is a promising treatment for pediatric patients with relapsed or refractory T-cell acute lymphoblastic leukemia (T-ALL). We describe a case...
10.
Gorfinkel L, Raghunandan S, Watkins B, Hebert K, Neuberg D, Bratrude B, et al.
Bone Marrow Transplant
. 2024 Feb;
59(5):680-687.
PMID: 38383714
Chronic graft-versus-host-disease (cGVHD) is divided into two subtypes: classic (absence of acute GVHD features) and overlap cGVHD ('ocGVHD'), in which both chronic and acute GVHD clinical features are present simultaneously....